DNA methylation-based classification of central nervous system tumours

Area of Science:

• Oncology
• Pathology
• Bioinformatics

Background:

• Accurate cancer diagnosis is vital for patient management.
• Central nervous system tumors present diagnostic challenges due to high variability.
• Standard histopathological diagnosis shows significant inter-observer variability.

Purpose of the Study:

• To develop and apply a DNA methylation-based classification for central nervous system tumors.
• To assess the impact of this method on diagnostic precision in a routine setting.
• To create an accessible online tool for tumor classification.

Main Methods:

• Comprehensive DNA methylation profiling of central nervous system tumors.
• Development of a machine-learning-based classifier.
• Validation in a routine diagnostic setting with prospective cases.
• Creation of a free, cloud-based online classifier tool.

Main Results:

• The DNA methylation-based approach provides accurate classification across all central nervous system tumor entities and age groups.
• Diagnostic precision improved significantly compared to standard methods.
• Up to 12% of prospective cases showed a change in diagnosis.
• The online classifier tool requires no additional onsite data processing.

Conclusions:

• DNA methylation-based classification offers a standardized and precise method for central nervous system tumors.
• This approach has the potential to transform tumor pathology and improve patient care.
• The developed blueprint can guide the creation of similar classifiers for other cancer types.